Human lymphoblast cells from a female patient diagnosed with Alzheimer's disease (AD) possessing the missense mutation TREM2 p.R47H were used to generate integration-free induced pluripotent stem cells (iPSCs) employing episomal plasmids expressing OCT4, SOX2, NANOG, LIN28, c-MYC and L-MYC. The iPSCs retained the TREM2 mutation, and were defined as pluripotent based on (i) expression of pluripotent-associated markers, (ii) embryoid body-based differentiation into cell types representative of the three germ layers and (iii) the similarity between the transcriptomes of the iPSC line and the human embryonic stem cell line H1 with a Pearson correlation of 0.961.
.)
Resource details
Lymphoblast cells (Lymph4), derived from a 67-year-old AD patient with the TREM2 missense mutation, p.R47H, (Cuyvers et al., 2014) were reprogrammed employing oriP/EBNA-1-based episomal plasmids expressing OCT4, SOX2, KLF4, C-MYC, L-MYC, LIN28 and a p53 shRNA. Clone A and B of AD2-4 iPSC line were negative for EBNA-1 and oriP (Fig. 1A) . Pluripotency was confirmed by (i) expression of OCT4, SOX2, c-MYC, NANOG, TRA-1-60 and TRA-1-81 (Fig. 1B) and (ii) embryoid body (EB)-based spontaneous differentiation into cell types representative of the three germ layers, namely ectoderm (Nestin, PAX6), mesoderm (SMA -smooth muscle actin) and endoderm (SOX17) (Fig.  1C) .
The DNA fingerprint of AD2-4 iPSC line was identical to the parental lymphoblast line Lymph4 (Fig.1D ). Karyotype analysis was female (XX) and both lines exhibited a normal diploid chromosomal content ( 
Materials and methods

Ethic statements
The EBV-transformed lymphoblastoid cell line Lymph4, used for the generation of the iPSC line AD2-4, was generated from peripheral blood lymphocytes from a 67-year-old female donor diagnosed with Alzheimer's disease. The research protocol was approved by the Ethics Committee of the University Hospital Antwerp and the University of Antwerp, Belgium.
Cell culture
The lymphoblast cell line Lymph4 (Cuyvers et al., 2014) was cultured in RPMI1640 supplemented with 15% fetal bovine serum (Invitrogen™), 1% Glutamax (Invitrogen™), 1% Sodium pyruvate (Invitrogen™) and 1% Penicillin/Streptomycin (Invitrogen™) at 37°C and 5% CO 2 .
Derivation of the iPS cell line
Lymphoblast cells (Lymph4) were reprogrammed by nucleofection of oriP/EBNA-1-based episomal plasmids (expressing OCT4, SOX2, KLF4, L-MYC, LIN28 and a p53 shRNA) (Okita et al., 2011) at the Biomedicum Stem Cell Center, University of Helsinki, Finland, (http:// research.med.helsinki.fi/neuro/Otonkoski/core/default.html) as a service. The iPSCs were cultured under feeder-free conditions on Matrigel®-coated plates in E8 medium (Invitrogen™).
Polymerase chain reaction
RT-PCR to assess the expression levels of the transgene and endogenous stem cell markers were carried out by the Biomediucm Stem Cell Center, University of Helsinki, Finland.
Embryoid body formation
Embryoid body (EB) formation was carried out as described in (Schröter et al., 2016b) . In brief, after culturing of the iPSCs in ultralow attachment flask (Corning) in FDTA medium, the EBs were replated onto gelatin-coated plates, again in FDTA medium lacking bFGF and Dorsomorphin (Frank et al., 2012) .
Immunocytochemistry
Immunocytochemistry was performed as described in (Schröter et al., 2016b; Schröter et al., 2016a) except for the germ layers staining. The following antibodies were used: rabbit anti-Nestin (Sigma Aldrich; 1:1000), mouse anti-PAX6 (SYSY, 1:1000), mouse anti-SMA (Cell Signaling; 1:1000) and mouse anti-SOX17 (Novus Biological, 1:500). The fluorescent images obtained by an inverse fluorescence microscope LSM 700 (Carl Zeiss) and analyzed employing Adobe Photoshop software (Adobe, USA).
Karyotype analysis
Karyotype analysis was evaluated and performed at the Institute of Human Genetics and Anthropology, Heinrich-Heine-University, Düsseldorf. Twenty-six and twenty-five metaphases were counted for the parental lymphoblast line Lymph4 and the iPSC line AD2-4, respectively.
DNA fingerprinting
Genomic DNA was isolated according to the manufacturer protocol from the lymphoblast line Lymph4, the AD2-4 iPSC line and the human embryonic stem cell line (H1). The STR analysis was performed by PCR amplification with specific primers (Prigione et al., 2011; Wang and Adjaye, 2011) .
Bidirectional Sanger sequencing
Genotyping of TREM2 p.R47H was performed on genomic DNA from iPSC line AD2-4 by PCR amplification and Sanger sequencing of exon 2 as described in (Cuyvers et al., 2014; Schröter et al., 2016b) .
RNA-based microarray analysis
RNA-based microarray analysis was performed as described in (Schröter et al., 2016b; Schröter et al., 2016a) . Microarray analysis was outsourced to the Genomics/Transcriptomic Laboratory of the BMFZ, Heinrich-Heine-University, Düsseldorf.
